{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T14:36:57Z","timestamp":1716820617924},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,26]]},"DOI":"10.7759\/cureus.41007","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T02:32:40Z","timestamp":1687833160000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment"],"prefix":"10.7759","author":[{"given":"David","family":"Allison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa","family":"Hajjiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Manon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Campbell-Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhalika","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Setty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.85gr.18001","article-title":"Kidney transplant: new opportunities and challenges","volume":"85","author":"Augustine J","year":"2018","unstructured":"Augustine J. Kidney transplant: new opportunities and challenges. Cleve Clin J Med. 2018, 85:138-44. 10.3949\/ccjm.85gr.18001","journal-title":"Cleve Clin J Med"},{"key":"ref2","article-title":"","author":"Himmelfarb J","year":"2019","unstructured":"Himmelfarb J, Ikizler T. Chronic Kidney Disease, Dialysis, and Transplantation, 4th Ed. Elsevier, Philadelphia; 2019."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 annual data report: kidney","volume":"23","author":"Lentine KL","year":"2023","unstructured":"Lentine KL, Smith JM, Miller JM, et al.. OPTN\/SRTR 2021 annual data report: kidney. Am J Transplant. 2023, 23:S21-S120. 10.1016\/j.ajt.2023.02.004","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp779","article-title":"The 'blood group O problem' in kidney transplantation--time to change?","volume":"25","author":"Glander P","year":"2010","unstructured":"Glander P, Budde K, Schmidt D, Fuller TF, Giessing M, Neumayer HH, Liefeldt L. The 'blood group O problem' in kidney transplantation--time to change?. Nephrol Dial Transplant. 2010, 25:1998-2004. 10.1093\/ndt\/gfp779","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun D","year":"2005","unstructured":"Dragun D, M\u00fcller DN, Br\u00e4sen JH, et al.. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005, 352:558-69. 10.1056\/NEJMoa035717","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12371","article-title":"The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes","volume":"27","author":"Banasik M","year":"2014","unstructured":"Banasik M, Boraty\u0144ska M, Ko\u015bcielska-Kasprzak K, et al.. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes. Transpl Int. 2014, 27:1029-38. 10.1111\/tri.12371","journal-title":"Transpl Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse C","year":"2018","unstructured":"Roufosse C, Simmonds N, Clahsen-van Groningen M, et al.. A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation. 2018, 102:1795-814. 10.1097\/TP.0000000000002366","journal-title":"Transplantation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100573","article-title":"Angiotensin II type 1 receptor antibodies in kidney transplantation: an evidence-based comprehensive review","volume":"34","author":"Sorohan BM","year":"2020","unstructured":"Sorohan BM, Ismail G, Leca N, et al.. Angiotensin II type 1 receptor antibodies in kidney transplantation: an evidence-based comprehensive review. Transplant Rev (Orlando). 2020, 34:100573. 10.1016\/j.trre.2020.100573","journal-title":"Transplant Rev (Orlando)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21657","article-title":"Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients","volume":"33","author":"Yamada C","year":"2018","unstructured":"Yamada C, Huang Y, Norman S, Naik A, Moussa O, Samaniego M, Cooling L. Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients. J Clin Apher. 2018, 33:673-7. 10.1002\/jca.21657","journal-title":"J Clin Apher"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2017.11.027","article-title":"Successful treatment of anti-angiotensin II type 1 receptor antibody-associated rejection in kidney transplantation: a case report","volume":"50","author":"Wiwattanathum P","year":"2018","unstructured":"Wiwattanathum P, Ingsathit A, Thammanichanond D, Worawichawong S. Successful treatment of anti-angiotensin II type 1 receptor antibody-associated rejection in kidney transplantation: a case report. Transplant Proc. 2018, 50:877-80. 10.1016\/j.transproceed.2017.11.027","journal-title":"Transplant Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12421","article-title":"Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation","volume":"20 Suppl 1","author":"Jobert A","year":"2015","unstructured":"Jobert A, Rao N, Deayton S, et al.. Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation. Nephrology (Carlton). 2015, 20 Suppl 1:10-2. 10.1111\/nep.12421","journal-title":"Nephrology (Carlton)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12441","article-title":"C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies","volume":"20","author":"Fuss A","year":"2015","unstructured":"Fuss A, Hope CM, Deayton S, Bennett GD, Holdsworth R, Carroll RP, Coates PT. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies. Nephrology (Carlton). 2015, 20:467-73. 10.1111\/nep.12441","journal-title":"Nephrology (Carlton)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.11.055","article-title":"Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation","volume":"47","author":"Lee J","year":"2015","unstructured":"Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation. Transplant Proc. 2015, 47:649-52. 10.1016\/j.transproceed.2014.11.055","journal-title":"Transplant Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.01.009","article-title":"Presentation and outcomes of antibody-mediated rejection associated with angiotensin II receptor 1 antibodies among kidney transplant recipients","volume":"53","author":"Abuzeineh M","year":"2021","unstructured":"Abuzeineh M, Kyeso Y, Philogene MC, Alachkar N, Alasfar S. Presentation and outcomes of antibody-mediated rejection associated with angiotensin II receptor 1 antibodies among kidney transplant recipients. Transplant Proc. 2021, 53:1501-8. 10.1016\/j.transproceed.2021.01.009","journal-title":"Transplant Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163146-angiotensin-ii-type-1-receptor-antibody-mediated-kidney-rejection-unresponsive-to-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:28Z","timestamp":1707508828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163146-angiotensin-ii-type-1-receptor-antibody-mediated-kidney-rejection-unresponsive-to-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.41007","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}